|
🐜
|
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
93 auth.
M. Peifer,
L. Fernandez-Cuesta,
M. Sos,
J. George,
D. Seidel,
L. Kasper,
Dennis Plenker,
F. Leenders,
Ruping Sun,
T. Zander,
R. Menon,
Mirjam Koker,
Ilona Dahmen,
C. Müller,
V. D. Cerbo,
...
H. Schildhaus,
J. Altmüller,
Ingelore Baessmann,
C. Becker,
B. D. Wilde,
J. Vandesompele,
D. Böhm,
S. Ansén,
F. Gabler,
Ines Wilkening,
Stefanie Heynck,
J. Heuckmann,
Xin Lu,
S. Carter,
K. Cibulskis,
S. Banerji,
G. Getz,
Kwon-Sik Park,
D. Rauh,
C. Grütter,
M. Fischer,
L. Pasqualucci,
Gavin Wright,
Z. Wainer,
P. Russell,
I. Petersen,
Yuan-Hua Chen,
E. Stoelben,
C. Ludwig,
P. Schnabel,
H. Hoffmann,
T. Muley,
M. Brockmann,
W. Engel‐Riedel,
L. Muscarella,
V. Fazio,
H. Groen,
W. Timens,
H. Sietsma,
E. Thunnissen,
E. Smit,
D. Heideman,
P. Snijders,
F. Cappuzzo,
C. Ligorio,
S. Damiani,
J. Field,
S. Solberg,
O. Brustugun,
M. Lund-Iversen,
J. Sänger,
J. Clement,
A. Soltermann,
H. Moch,
W. Weder,
B. Solomon,
J. Soria,
P. Validire,
B. Besse,
E. Brambilla,
C. Brambilla,
S. Lantuejoul,
P. Lorimier,
P. Schneider,
M. Hallek,
W. Pao,
M. Meyerson,
J. Sage,
J. Shendure,
R. Schneider,
R. Büttner,
J. Wolf,
P. Nürnberg,
S. Perner,
L. Heukamp,
Paul K. Brindle,
S. Haas,
Roman K. Thomas
|
10 |
2012 |
10
🐜
|
|
🐜
|
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)
32 auth.
F. Barlesi,
J. Mazières,
J. Merlio,
D. Debieuvre,
J. Mosser,
H. Léna,
L. Ouafik,
B. Besse,
I. Rouquette,
V. Westeel,
F. Escande,
I. Monnet,
A. Lemoine,
R. Veillon,
H. Blons,
...
C. Audigier-Valette,
P. Bringuier,
R. Lamy,
M. Beau-Faller,
J. Pujol,
J. Sabourin,
F. Penault-Llorca,
M. Denis,
S. Lantuejoul,
F. Morin,
Q. Tran,
P. Missy,
A. Langlais,
B. Milleron,
J. Cadranel,
J. Soria,
G. Zalcman
|
9 |
2016 |
9
🐜
|
|
🐜
|
The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015.
19 auth.
A. Nicholson,
M. Tsao,
M. Beasley,
A. Borczuk,
E. Brambilla,
W. Cooper,
S. Dacic,
D. Jain,
K. Kerr,
S. Lantuejoul,
...
M. Noguchi,
M. Papotti,
N. Rekhtman,
G. Scagliotti,
P. V. Van Schil,
L. Sholl,
Y. Yatabe,
A. Yoshida,
W. Travis
|
9 |
2021 |
9
🐜
|
|
🐜
|
PD‐L1 Immunohistochemistry Comparability Study in Real‐Life Clinical Samples: Results of Blueprint Phase 2 Project
28 auth.
M. Tsao,
K. Kerr,
M. Kockx,
M. Beasley,
A. Borczuk,
J. Botling,
L. Bubendorf,
L. Chirieac,
Gang Chen,
T. Chou,
Jin-Haeng Chung,
S. Dacic,
S. Lantuejoul,
M. Mino‐Kenudson,
A. Moreira,
...
A. Nicholson,
M. Noguchi,
G. Pelosi,
C. Poleri,
P. Russell,
J. Sauter,
E. Thunnissen,
I. Wistuba,
Hui Yu,
M. Wynes,
M. Pintilie,
Y. Yatabe,
F. Hirsch
|
9 |
2018 |
9
🐜
|
|
🐜
|
Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers
17 auth.
S. Rousseaux,
A. Debernardi,
Baptiste Jacquiau,
Anne-Laure Vitte,
A. Vésin,
H. Nagy-Mignotte,
D. Moro-Sibilot,
P. Brichon,
S. Lantuejoul,
P. Hainaut,
...
J. Laffaire,
A. de Reyniès,
D. Beer,
J. Timsit,
C. Brambilla,
E. Brambilla,
S. Khochbin
|
8 |
2013 |
8
🐜
|
|
🐜
|
A Genomics-Based Classification of Human Lung Tumors
116 auth.
D. Seidel,
T. Zander,
L. Heukamp,
M. Peifer,
M. Bos,
L. Fernandez-Cuesta,
F. Leenders,
Xin Lu,
S. Ansén,
M. Gardizi,
C. Nguyen,
J. Berg,
P. Russell,
Z. Wainer,
H. Schildhaus,
...
Toni-Maree Rogers,
B. Solomon,
W. Pao,
S. Carter,
G. Getz,
D. Hayes,
M. Wilkerson,
E. Thunnissen,
W. Travis,
S. Perner,
Gavin Wright,
E. Brambilla,
R. Buettner,
J. Wolf,
Roman K. Thomas,
F. Gabler,
Ines Wilkening,
C. Mueller,
Ilona Dahmen,
R. Menon,
Katharina Koenig,
K. Albus,
S. Merkelbach-Bruse,
J. Fassunke,
K. Schmitz,
Helen Kuenstlinger,
M. Kleine,
E. Binot,
S. Querings,
J. Altmueller,
Ingelore Boessmann,
Peter Nuemberg,
P. Schneider,
Magdalena Bogus,
A. Soltermann,
H. Moch,
O. Brustugun,
S. Solberg,
M. Lund-Iversen,
Å. Helland,
T. Muley,
H. Hoffmann,
P. Schnabel,
Yuan-Hua Chen,
H. Groen,
W. Timens,
H. Sietsma,
J. Clement,
W. Weder,
J. Saenger,
E. Stoelben,
C. Ludwig,
W. Engel‐Riedel,
E. Smit,
D. Heideman,
P. Snijders,
L. Nogova,
M. Sos,
C. Mattonet,
K. Toepelt,
M. Scheffler,
E. Goekkurt,
R. Kappes,
S. Krueger,
K. Kambartel,
D. Behringer,
W. Schulte,
W. Galetke,
W. Randerath,
M. Heldwein,
A. Schlesinger,
M. Serke,
K. Hekmat,
K. Frank,
R. Schnell,
M. Reiser,
Ali-Nuri Huenerlituerkoglu,
S. Schmitz,
L. Meffert,
Y. Ko,
Markus Litt-Lampe,
U. Gerigk,
R. Fricke,
B. Besse,
C. Brambilla,
S. Lantuejoul,
P. Lorimier,
D. Moro-Sibilot,
F. Cappuzzo,
C. Ligorio,
S. Damiani,
J. Field,
R. Hyde,
P. Validire,
P. Girard,
L. Muscarella,
V. Fazio,
M. Hallek,
J. Soria,
V. Achter,
Ulrich Lang
|
8 |
2013 |
8
🐜
|
|
🐜
|
TUNEL Apoptotic Cell Detection in Tissue Sections: Critical Evaluation and Improvement
7 auth.
F. Labat-Moleur,
C. Guillermet,
P. Lorimier,
C. Robert,
S. Lantuejoul,
E. Brambilla,
...
A. Negoescu
|
8 |
1998 |
8
🐜
|
|
🐜
|
Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial.
19 auth.
A. Scherpereel,
J. Mazières,
L. Greillier,
S. Lantuejoul,
P. Dô,
O. Bylicki,
I. Monnet,
R. Corre,
C. Audigier-Valette,
M. Locatelli-Sanchez,
...
O. Molinier,
F. Guisier,
T. Urban,
C. Ligeza-poisson,
D. Planchard,
E. Amour,
F. Morin,
D. Moro-Sibilot,
G. Zalcman
|
8 |
2019 |
8
🐜
|
|
🐜
|
Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer.
17 auth.
E. Brambilla,
G. Le Teuff,
S. Marguet,
S. Lantuejoul,
A. Dunant,
S. Graziano,
R. Pirker,
J. Douillard,
T. le Chevalier,
M. Filipits,
...
R. Rosell,
R. Kratzke,
H. Popper,
J. Soria,
F. Shepherd,
L. Seymour,
M. Tsao
|
8 |
2016 |
8
🐜
|
|
🐜
|
Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker
19 auth.
V. Hofman,
C. Bonnetaud,
M. Ilié,
P. Vielh,
J. Vignaud,
J. Fléjou,
S. Lantuejoul,
E. Piaton,
N. Mourad,
C. Butori,
...
E. Selva,
M. Poudenx,
S. Sibon,
S. Kelhef,
N. Vénissac,
J. Jais,
J. Mouroux,
T. Molina,
P. Hofman
|
8 |
2010 |
8
🐜
|
|
🐜
|
SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
32 auth.
F. Le Loarer,
S. Watson,
G. Pierron,
V. D. De Montpreville,
S. Ballet,
N. Firmin,
A. Auguste,
D. Pissaloux,
S. Boyault,
S. Paindavoine,
P. Dechelotte,
B. Besse,
J. Vignaud,
M. Brevet,
E. Fadel,
...
W. Richer,
I. Treilleux,
J. Masliah-Planchon,
M. Devouassoux-Shisheboran,
G. Zalcman,
Y. Allory,
F. Bourdeaut,
F. Thivolet-Béjui,
D. Ranchère‐Vince,
N. Girard,
S. Lantuejoul,
F. Galateau-Salle,
J. Coindre,
A. Leary,
O. Delattre,
J. Blay,
F. Tirode
|
8 |
2015 |
8
🐜
|
|
🐜
|
Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
7 auth.
E. Brambilla,
A. Negoescu,
S. Gazzeri,
S. Lantuejoul,
D. Moro,
C. Brambilla,
...
J. Coll
|
8 |
1996 |
8
🐜
|
